Concepedia

Ruth Schwab

RS

Statistics

Publications

4

Citations

476

H-Index

4

Active since

2002

Affiliations

Ludwig-Maximilians-Universität München(Current)

Ruth Schwab is an author at Ludwig-Maximilians-Universität München specializing in molecular oncology, life sciences, and tyrosine kinase receptors.

Publications per year

2002–2003

4

Publications

4

Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.

Karsten Spiekermann, Ksenia Bagrintseva, Ruth Schwab et al. · PubMed · 2003 · 187 citations

Life Sciences, Genetics, Oncology +15

The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3

Karsten Spiekermann, Ralf J. Dirschinger, Ruth Schwab et al. · Blood · 2003 · 115 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells

Karsten Spiekermann, Michael J. Pau, Ruth Schwab et al. · Experimental Hematology · 2002 · 100 citations · Full text

Life Sciences, Hematology, Molecular Biology +16

Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD–transformed hematopoietic cells

Ksenia Bagrintseva, Ruth Schwab, Tobias Kohl et al. · Blood · 2003 · 74 citations · Full text

Medicine, Oncology, Pharmacology +16

1–4 of 4